Sotera Health (SHC) Earnings Analysis

Sotera Health (SHC) has no confirmed upcoming earnings date. Last quarter (2025-08-08) it beat with EPS 0.2 USD vs 0.17 USD est (+17.6%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E 42.04.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does SHC next report earnings?

No confirmed upcoming earnings date is currently scheduled for SHC. This page updates as the calendar is published.

SHC earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-08-080.2 USD0.17 USD+17.6%Beat
2025-05-010.14 USD0.12 USD+16.7%Beat
2025-02-270.21 USD0.21 USD0%Beat
2024-08-050.19 USD0.17 USD+11.8%Beat

Beat rate: 4/4 (100%) over reported quarters with consensus data.

SHC valuation and analyst view

Trailing P/E42.04
Trailing EPS0.41349 USD
Price / book7.91
Dividend yield0.00%
Market cap4.94B
Analyst consensusBuy (11 buy / 1 hold / 0 sell)
Avg price target19.5 USD

Related research pages

Frequently asked questions

When is Sotera Health (SHC)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for SHC. This page updates as the calendar is published.

Did SHC beat earnings last quarter?

In its 2025-08-08 report, SHC posted EPS of 0.2 USD versus a 0.17 USD estimate — a beat of 17.6%.

What is SHC's earnings track record?

Over the last 4 reported quarters with consensus data, SHC beat estimates 4 times (100%).

What is SHC's current P/E ratio and EPS?

SHC trades at a trailing P/E of 42.04 on trailing EPS of 0.4134902610508728 USD.

What do analysts rate SHC?

Analyst consensus is "Buy" across 12 ratings (0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 19.5 USD.